- BGDO Annual Meeting 2020: Pancreatic cancer advances - New therapeutic targets in GI Cancers - Crowne Plaza Burussels Airport - 11 January 2020 - Go to details
- BGDO General Assembly: BGDO Office - 12 June 2019 - Go to details
- BGDO Digestive Oncology Course: Quality indicators and NGS/molecular pathology in GI cancers - Château de la Poste - Maillen - 26-27 April 2019 - Go to details
- Belgian Week of Gastroenterology 2019: BGDO Session - Hilton Antwerp - 22 Feb. 2019 - Go to details
- BGDO Annual Meeting 2019: Curative approach in oesophageal cancer and peritoneal carcinomatosis in 2019 - Crowne Plaza Burussels Airport - 12 January 2019 - Go to details
- BGDO Annual Meeting: Adjuvant therapy: today & tomorrow - Crowne Plaza Brussels Airport - 13 JAN 2018 - Go to details
- Belgian Week of Gastroenterology 2018: BGDO Session - Hilton Antwerp - 22 Feb. 2018 - Go to details
BGDO Annual Meeting 2020
Pancreatic cancer advances - New therapeutic targets in GI Cancers
BGDO General Assembly
The BGDO Board is pleased to invite its membres to the BGDO General Assembly on Wednesday 12 June at 19:30.
- Approval of the agenda
- Approval of the annual financial statements for the accounting period of 1 January 2018 till 31 December 2018
- Approval of the estimated expenses 2019
- Release of the board members from any liability for the accounting year 2018
Venue: Leuvensesteenweg 643 – 1930 Zaventem (entrance back of the building)
Who can participate: All BGDO members who have paid their membership fee are entitled to participate in the General Assembly whether in person or by proxy. (only one proxy per person)
Registration: via this link
BGDO Digestive Oncology Course
Quality indicators and NGS/molecular pathology in GI cancers
The BGDO is pleased to invite you for the next Digestive Oncology Course for clinicians.
Due to rapid technical advances, steeply declining sequencing costs, and the ever-increasing number of targeted therapies, it can be expected that extensive tumor sequencing such as whole-exome and whole-genome sequencing will soon be applied in standard care. However, the complexity of interpreting genomic data is hindering its implementation in the clinical context.
This course aims at making clinicians familiar with the types of genomic variants reported by the laboratory and the technology used to determine the results, including limitations of current testing methodologies and reports.
A special emphasis is put on the main molecular alterations in gastro-intestinal cancer and the direct perspectives for targeted therapies. This course applies to clinicians interested in digestive oncology, but without profound knowledge of recent progression in molecular biology.
Discover the programme
Time: Friday 26 April 10:30 - 18:30 | Saturday 27 April 09:15 - 12:30
On Friday evening a barbecue is foreseen in an hunting lodge. We will eat in the forest around a nice fire.
Venue: Château de la poste ● Ronchinne, 25 - 5330 Maillen . www.chateaudelaposte.com
Philippe AFTIMOS, Institut Bordet Brussels / Kathleen CLAES, UGent / Karin DAHAN, IPG Gosselies / Jeroen DEKERVEL, UZ Leuven / Nicky D’HAENE, ULB Erasme / Karen GEBOES UZ Gent / Vincent HAUFROID, UCL Brussels / Patrick PAUWELS, UZ Antwerpen / Hans PRENEN, UZ Antwerpen / Sabine TEJPAR, UZ Leuven / Isabelle VANDEN BEMPT, UZ Leuven / Marc VAN DEN BULCKE, Cancer Centre Sciensano / Liesbet VAN EYCKEN, Cancer Registry.
Belgian Week of Gastroenterology 2019
BGDO Annual Meeting 2019
Curative approach in oesophageal cancer and peritoneal carcinomatosis in 2019
BGDO Annual Meeting
Adjuvant therapy: today & tomorrow
The meeting will explore original and interesting topics on ADJUVANT THERAPY: TODAY & TOMORROW.
First, we will start with the General Assembly. A good opportunity to have short glimpse on the new website, the achieved goals, the new collaboration with the FFCD and an update on the ongoing and upcoming trials.
Two highly up-to-date talks will open the Innovation in Oncology session:
- Prof Laurent-Puig addresses the value of Liquid Biopsy in GI cancers, a very hot topic in the near future!
- Another underused practice to improve survival is to follow patient care through Patient-Reported Outcomes (PRO). Prof Marc Peeterswill comment the engaging results that can be obtained by interacting with patients more closely.
This year has been marked by several important trials in the adjuvant setting:
- The IDEA consortium looked at the role of the length of adjuvant chemotherapy in colorectal cancer. Prof Timothy Iveson led the SCOT trial with very interesting results in this setting and will give us the privilege to listen to his analysis.
- In gastric cancer, the FLOT trial sets a new standard in perioperative care, which will be presented by Prof Alain Hendlisz.
- Prof Chris Verslype will discuss the value of capecitabine in hard-to-treat pancreatic and biliary tract cancers.
Last but not least Prof Marc Buyse, world-renowned statistician in the field of oncology, will propose new ways to address clinical trial design, benefit assessment and futuristic statistical methods.
A huge thank you to all our Sponsors, Majors and Regulars.